Clinical Trial Update: Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rosiglitazone for type 2 diabetes mellitus, including assessment of arterial plaque, has completed. Sponsor: GlaxoSmithKline…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandia (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Non-insulin-dependent Diabetes Mellitus | Phase 3 | Status: COMPLETED